• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Merck & Co (NY:MRK)

    98.87 -0.85 (-0.85%)
    Streaming Delayed Price Updated: 2:32 PM EST, Dec 8, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Merck & Co

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    99 100 Next >
    News headline image
    Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones? ↗
    With yields between 3.4% and 6.8%, you'll need to think carefully about the highest yields in the Dow before you buy them. 
    Via The Motley Fool
    Topics Economy Stocks
    News headline image
    Merck's Stock is Suddenly Soaring, but Is the Struggling Healthcare Giant a Buy? ↗
    After a long hiatus, why are the bulls so willing to buy in now? 
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Do These 3 Healthcare Stocks Need a Checkup? ↗
    These three drugmakers are all well off their recent highs. Is this a sign of opportunity or risk? 
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Trading Near Its 52-Week Low, Is Summit Therapeutics a Good Stock to Buy Right Now? ↗
    The healthcare stock could skyrocket if ivonescimab obtains approval from regulators, but there's still plenty of risk here. 
    Via The Motley Fool
    News headline image
    Is This Pharmaceutical Giant a Buy After a Major Acquisition? ↗
    The rebound is well underway. 
    Via The Motley Fool
    Topics Death
    News headline image
    These Are the 3 Hottest Stocks in the S&P 500 Heading Into the New Year. Should You Invest in Them? ↗
    After tepid performances throughout most of 2025, these stocks are showing some upward momentum. 
    Via The Motley Fool
    Topics Stocks
    News headline image
    With Netflix's 10-for-1 Stock Split Complete, Here Are 3 Growth Stocks to Buy in December That Could Issue Stock Splits in 2026 ↗
    Surging stock prices and earnings growth potential make Meta Platforms, ASML, and Eli Lilly ripe for stock splits in the new year. 
    Via The Motley Fool
    Topics Artificial Intelligence Economy Stocks
    News headline image
    FDA Conditionally Approves Merck Animal Health's EXZOLT™ CATTLE-CA1 for the Prevention and Treatment of New World Screwworm (Cochliomyia hominivorax) Larvae (myiasis)
    From Merck & Co., Inc.
    Via Business Wire
    News headline image
    3 Top ETFs I Plan to Pile Into in December to Boost My Passive Income in 2026 ↗
    These ETFs can provide me with lots of passive income. 
    Via The Motley Fool
    Topics ETFs Stocks
    News headline image
    Global Prescription Drug Market Poised for Trillion-Dollar Surge by 2035
    The global prescription drugs market is on the cusp of a significant expansion, with recent market reviews and forecasts projecting a robust growth trajectory through 2035. This anticipated surge,... 
    Via MarketMinute
    Topics Artificial Intelligence Death Intellectual Property
    News headline image
    Wall Street's Tentative Triumph: Dow, S&P 500, Nasdaq Edge Higher Amidst Shifting Tides
    Wall Street has recently concluded a tumultuous yet ultimately resilient period, with the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite all managing to edge higher in late November and... 
    Via MarketMinute
    Topics Artificial Intelligence Bonds Economy
    Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now
    Via Investor Brand Network
    Topics Government
    News headline image
    Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now
    From BioMedWire
    Via GlobeNewswire
    News headline image
    2 Monster Stocks in the Making to Buy and Hold ↗
    There's still time to get in on these rising stars. 
    Via The Motley Fool
    News headline image
    1 Value Stock to Target This Week and 2 We Question
    The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued... 
    Via StockStory
    News headline image
    Global Markets Brace as Treasury Yields Surge Amidst BOJ Speculation and Risk Aversion
    As December 1, 2025, dawns, global financial markets are grappling with a significant uptick in Treasury yields, a movement primarily catalyzed by a substantial sell-off in Japanese government debt and... 
    Via MarketMinute
    Topics Bonds Economy Stocks
    News headline image
    Treasury Yields Surge Amid Global Shifts and Fiscal Concerns: A Deep Dive into Market Implications
    New York, NY – December 1, 2025 – U.S. Treasury yields have experienced a significant climb today, marking a pivotal moment for financial markets. This ascent, driven by a complex interplay of global... 
    Via MarketMinute
    Topics Bonds Credit Cards Economy
    News headline image
    Merck Showcases Data for Alzheimer's Disease Candidates MK-2214 and MK-1167 at CTAD 2025
    From Merck Sharp & Dohme
    Via Business Wire
    News headline image
    These Underrated Companies Could Be "Training-Wheels" Stocks for Long-Term Wealth Builders ↗
    If you are thinking in decades and not days, this trio of dividend stocks could be the perfect starting point for your fledgling portfolio. 
    Via The Motley Fool
    Topics Energy Intellectual Property
    News headline image
    3 Non-AI Stocks to Buy: MRK, UPS, CVX ↗
    There are plenty of potential winners outside the world of AI. 
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Should You Buy This Blue Chip Pharmaceutical Stock That Just Popped 3.8%? ↗
    The struggling pharmaceutical giant is showing signs of life. 
    Via The Motley Fool
    News headline image
    Dow Industrials Erase November Losses: A Beacon of Optimism Amidst Market Crossroads
    The Dow Jones Industrial Average (DJIA) has staged a remarkable comeback, successfully erasing its November 2025 losses by the month's final trading day, Friday, November 28, 2025. This significant... 
    Via MarketMinute
    Topics Artificial Intelligence ETFs Economy
    News headline image
    Merck & Co. Inc. (NYSE:MRK): A Dividend Stock with Strong Profitability and Financial Health ↗
    Discover Merck (MRK), a top dividend stock with a 3.58% yield, strong growth history, and excellent profitability for reliable income. 
    Via Chartmill
    News headline image
    Merck to Participate in the Citi 2025 Global Healthcare Conference
    From Merck & Co., Inc.
    Via Business Wire
    News headline image
    Merck to Participate in the 8th Annual Evercore ISI HealthCONx Conference
    From Merck Sharp & Dohme
    Via Business Wire
    News headline image
    Dow Jones Navigates Volatility Amidst AI Bubble Fears and Shifting Fed Expectations
    The Dow Jones Industrial Average has been on a roller-coaster ride in November 2025, experiencing significant volatility and sending mixed signals across various sectors. While the index achieved a... 
    Via MarketMinute
    Topics Artificial Intelligence Bonds Economy
    News headline image
    Stocks making big moves yesterday: Meta, Tenet Healthcare, Wynn Resorts, Elevance Health, and Merck
    Check out the companies making headlines yesterday: 
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    Why Merck (MRK) Stock Is Trading Up Today
    Shares of global pharmaceutical company Merck (NYSE:MRK) jumped 4.1% in the afternoon session after Wells Fargo upgraded the stock to "Overweight" from "Equal-Weight," citing confidence in the... 
    Via StockStory
    Topics Artificial Intelligence Economy
    Biotech Valuations Rise as New Clinical Platforms Show Progress
    Via Investor Brand Network
    News headline image
    Biotech Valuations Rise as New Clinical Platforms Show Progress
    From BioMedWire
    Via GlobeNewswire
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    99 100 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.